The future of HER2 targeted therapies looks promising with ongoing research and clinical trials. New drugs and combination therapies are being developed to target HER2 more effectively and with fewer side effects. The advent of personalized medicine and genomic profiling is expected to further refine these treatments, making them more effective for individual patients.
